3/6/24-Prevention and Management of Sedative, Hypnotic and Anxiolytic Use

Presentation Resources

-Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction. 2009 Jan;104(1):13-24. doi: 10.1111/j.1360-0443.2008.02364.x. Epub 2008 Oct

Abstract Only-https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1360-0443.2008.02364.x

Reviewed at https://www.ncbi.nlm.nih.gov/books/NBK77002/

-Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005194.

https://pubmed.ncbi.nlm.nih.gov/16856084/

Related Resources

-Breggin, P. R., (2013). Psychiatric Drug Withdrawal: A Guide for Prescribers, Therapists,

Patients and Their Families. Springer.

-Pollmann AS, Murphy AL, Bergman JC, Gardner DM. Deprescribing benzodiazepines and

Z-drugs in community-dwelling adults: a scoping review. BMC Pharmacol Toxicol.

2015;16:19. Published 2015 Jul 4. doi:10.1186/s40360-015-0019-8

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491204/

-U.S. Department of Veterans’ Affairs. (2016). Re-evaluating the Use of Benzodiazepines: A

Quick Reference Guide. Washington DC: www.va.gov

https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/Academic_Detailing_Educational_Material_Catalog/23_Benzodiazepine_Provider_AD_Quick_Reference_Guide_IB10_929.pdf

-Stahl, S. Anxiety disorders and anxiolytics. Stahl’s Essential Psychopharmacology Neuroscientific Basis and Practice Application. 2018.

-Smith, R. V., Havens, J. R., and Walsh, S. L. (2016) Gabapentin misuse, abuse and

diversion: a systematic review. Addiction, 111: 1160– 1174. doi: 10.1111/add.13324.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573873/

-Trevor, A. (2018). Sedative-Hypnotic Drugs. Basic and Clinical Pharmacology, 15th ed. New

York NY: McGraw-Hill.